Skip to main content

Charcot Arthropathy in the Diabetic Foot

  • Chapter
  • First Online:
The Diabetic Foot

Part of the book series: Contemporary Diabetes ((CDI))

Abstract

The Charcot foot is a devastating but oftentimes preventable complication of diabetes with peripheral neuropathy. The condition has several synonyms including Charcot’s arthropathy, Charcot joint disease, Charcot syndrome, tabetic arthropathy, diabetic neuropathic osteoarthropathy, and many derivations or combinations thereof. It is named after Jean-Martin Charcot (1825–1893), a French neurologist who first described the joint disease associated with tabes dorsalis and named it the “arthropathy of locomotor ataxia.” In 1881, J-M Charcot presented his findings at the 7th International Medical Congress in London which was attended by many acclaimed physicians of the era. During this meeting the eponym “Charcot’s Disease” was designated by Sir James Paget to these degenerative neuropathic changes in bones and joints. Although W. Musgrave in 1703 and later J.K. Mitchell in 1831 ostensibly described osteoarthropathy associated with venereal disease and spinal cord lesions, respectively, Charcot’s name remains synonymous with neuropathic arthropathies regardless of etiology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Charcot JM. Sur quelaques arthropathies qui paraissent depender d’une lesion du cerveau ou de la moele epiniere. Arch Des Physiol Norm et Path. 1868;1:161–71.

    Google Scholar 

  2. Sanders LJ, Frykberg RG. The charcot foot. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. New York: Churchill Livingstone; 1991. p. 325–35.

    Google Scholar 

  3. Kelly M. John Kearsley Mitchell and the neurogenic theory of arthritis. J Hist Med. 1965;20:151–7.

    CAS  Google Scholar 

  4. Armstrong DG, Todd WF, Lavery LA, Harkless LB. The natural history of acute Charcot’s arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997;14:357–63.

    PubMed  CAS  Google Scholar 

  5. Mitchell JK. On a new practice in acute and chronic rheumatism. Am J Med Sci. 1831;8:55.

    Google Scholar 

  6. Jordan WR. Neuritic manifestations in diabetes ­mellitus. Arch Intern Med. 1936;57:307–12.

    Google Scholar 

  7. Bailey CC, Root HF. Neuropathic foot lesions in ­diabetes mellitus. N Engl J Med. 1947;236:397.

    Google Scholar 

  8. Sinha S, Munichoodapa CS, Kozak GP. Neuro­arthropathy (Charcot joints) in diabetes mellitus. Medicine. 1972;51:191–210.

    PubMed  CAS  Google Scholar 

  9. Frykberg RG, Kozak GP. Neuropathic arthropathy in the diabetic foot. Am Fam Physician. 1978;17:105.

    PubMed  CAS  Google Scholar 

  10. Sanders LJ, Frykberg RG. Charcot neuroarthropathy of the foot. In: JH B, MA P, editors. Levin and O’Neals The Diabetic Foot. 6th ed. St Louis: Mosby; 2001.

    Google Scholar 

  11. Cofield RH, Morrison MJ, Beabout JW. Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle. 1983;4:15–22.

    PubMed  CAS  Google Scholar 

  12. Lavery LA, Armstrong DG, Wunderlich RP, Boulton AJM, Tredwell JL. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–8.

    PubMed  Google Scholar 

  13. Frykberg RG, Kozak GP. The diabetic Charcot foot. In: Kozak GP, Campbell DR, Frykberg RG, Cavanagh PR, editors. Management of diabetic foot problems. 2nd ed. Philadelphia: WB Saunders; 1995.

    Google Scholar 

  14. Frykberg RG. Charcot foot: an update on pathogenesis and management. In: Boulton AJM, Connor H, Cavanagh PR, editors. The foot in diabetes. 3rd ed. Chichester, UK: Wiley; 2000.

    Google Scholar 

  15. Gazis A, Pound N, Macfarlane R, Treece K, Game F, Jeffcoate W. Mortality in patients with diabetic ­neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21(11):1243–6.

    PubMed  CAS  Google Scholar 

  16. Sohn MW, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care. 2009;32(5):816–21.

    PubMed  Google Scholar 

  17. van Baal J, Hubbard R, Game F, Jeffcoate W. Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care. 2010;33(5):1086–9.

    PubMed  Google Scholar 

  18. Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg. 2000;39(5 Suppl):S1–60.

    PubMed  CAS  Google Scholar 

  19. Bevilacqua NJ, Bowling F, Armstrong DG. The ­hatural history of Charcot neuroarthropathy. In: Frykberg RG, editor. The diabetic charcot foot: ­principals and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 13–28.

    Google Scholar 

  20. Brower AC, Allman RM. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology. 1981;139:349–54.

    PubMed  CAS  Google Scholar 

  21. Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabet Med. 2000;17(4):253–8.

    PubMed  CAS  Google Scholar 

  22. Boulton AJ. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47(8):1343–53.

    PubMed  CAS  Google Scholar 

  23. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47(3):457–63.

    PubMed  CAS  Google Scholar 

  24. Edelman SV, Kosofsky EM, Paul RA, Kozak GP. Neuro-osteoarthropathy (Charcot’s joint) in diabetes mellitus following revascularization surgery. Three case reports and a review of the literature. Arch Intern Med. 1987;147(8):1504–8.

    PubMed  CAS  Google Scholar 

  25. Banks AS, McGlamry ED. Charcot foot. J Am Podiatr Med Assoc. 1989;79:213–7.

    PubMed  CAS  Google Scholar 

  26. Gough A, Abraha H, Li F, et al. Measurement of markers of osteoclast activity in patients with acute and chronic diabetic Charcot arthropathy. Diabet Med. 1997;14(7):527–31.

    PubMed  CAS  Google Scholar 

  27. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care. 1995;18(1):34–8.

    PubMed  CAS  Google Scholar 

  28. Jirkovska A, Kasalicky P, Boucek P, Hosova J, Skibova J. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet Med. 2001;18(6):495–500.

    PubMed  CAS  Google Scholar 

  29. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45(8):1085–96.

    PubMed  CAS  Google Scholar 

  30. Foltz KD, Fallat LM, Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg. 2004;43(2):87–92.

    PubMed  Google Scholar 

  31. Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br. 2004;86(3):378–83.

    PubMed  CAS  Google Scholar 

  32. Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44(11):2032–7.

    PubMed  CAS  Google Scholar 

  33. Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Diabetologia. 2004;47(9):1488–92.

    PubMed  CAS  Google Scholar 

  34. Jeffcoate WJ, Game FL. New theories on the causes of the Charcot foot in diabetes. In: Frykberg RG, editor. The diabetic charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 29–44.

    Google Scholar 

  35. Eichenholtz SN. Charcot joints. Springfield: Charles C. Thomas; 1966.

    Google Scholar 

  36. Schon LC, Marks RM. The management of neuroarthropathic fracture-dislocations in the diabetic patient. Orthop Clin North Am. 1995;26(2):375–92.

    PubMed  CAS  Google Scholar 

  37. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38(1):34–40.

    PubMed  CAS  Google Scholar 

  38. Yu GV, Hudson JR. Evaluation and treatment of stage 0 Charcot’s neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc. 2002;92(4):210–20.

    PubMed  Google Scholar 

  39. Harris JR, Brand PW. Patterns of disintegration of the tarsus in the anesthetic foot. J Bone Joint Surg. 1966;48B(1):4–16.

    Google Scholar 

  40. Brodsky JW, Rouse AM. Exostectomy for symptomatic bony prominences in diabetic Charcot feet. Clin Orthop Relat Res. 1993;296:21–6.

    PubMed  Google Scholar 

  41. Schon LC, Weinfeld SB, Horton GA, Resch S. Radiographic and clinical classification of acquired midtarsus deformities. Foot Ankle Int. 1998;19(6):394–404.

    PubMed  CAS  Google Scholar 

  42. Frykberg RG, Rogers LC. Classification of the Charcot foot. In: Frykberg RG, editor. The diabetic charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 55–64.

    Google Scholar 

  43. Rogers LC, Bevilacqua NJ. The diagnosis of Charcot foot. Clin Podiatr Med Surg. 2008;25(1):43–51.

    PubMed  Google Scholar 

  44. Frykberg RG. Charcot arthropathy: pathogenesis and management. Wounds. 2000;12(6 Suppl B):35B–42.

    Google Scholar 

  45. Newman JH. Spontaneous dislocation in diabetic neuropathy. A report of six cases. J Bone Joint Surg Br. 1979;61(4):484–8.

    PubMed  Google Scholar 

  46. Lesko P, Maurer RC. Talonavicular dislocations and midfoot arthropathy in neuropathic diabetic feet. Natural course and principles of treatment. Clin Orthop Relat Res. 1989;240:226–31.

    PubMed  Google Scholar 

  47. Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23(6):796–800.

    PubMed  CAS  Google Scholar 

  48. El-Khoury GY, Kathol MH. Neuropathic fractures in patients with diabetes mellitus. Radiology. 1980;134(2):313–6.

    PubMed  CAS  Google Scholar 

  49. Kathol MH, el-Khoury GY, Moore TE, Marsh JL. Calcaneal insufficiency avulsion fractures in patients with diabetes mellitus. Radiology. 1991;180(3):725–9.

    PubMed  CAS  Google Scholar 

  50. Petrova NL, Foster AV, Edmonds ME. Difference in presentation of charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care. 2004;27(5):1235–6.

    PubMed  Google Scholar 

  51. Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg. 2002;91(2):195–201.

    PubMed  CAS  Google Scholar 

  52. McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK. Response of Charcot’s arthropathy to contact casting: assessment by quantitative techniques. Diabetologia. 2000;43(4):481–4.

    PubMed  CAS  Google Scholar 

  53. Trepman E, Nihal A, Pinzur MS. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26(1):46–63.

    PubMed  Google Scholar 

  54. Sella EJ, Grosser DM. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg. 2003;20(4):729–40.

    PubMed  Google Scholar 

  55. Wukich DK, Belczyk RJ. Silent neuropathic bone injuries and dislocations – stage 0. In: Frykberg RG, editor. The diabetic charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 117–30.

    Google Scholar 

  56. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current ­scintigraphic techniques. Arch Intern Med. 1989;149(10):2262–6.

    PubMed  CAS  Google Scholar 

  57. Schweitzer ME, Morrison WB. MR imaging of the diabetic foot. Radiol Clin North Am. 2004;42(1):61–71. vi.

    PubMed  Google Scholar 

  58. Palestro CJ, Mehta HH, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99 m sulfur colloid scintigraphy. J Nucl Med. 1998;39(2):346–50.

    PubMed  CAS  Google Scholar 

  59. Rogers LC, Bevilacqua NJ. Imaging of the Charcot foot. Clin Podiatr Med Surg. 2008;25(2):263–74.

    PubMed  Google Scholar 

  60. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35(4):280–3.

    PubMed  CAS  Google Scholar 

  61. Seabold JE, Flickinger FW, Kao SC, et al. Indium-111-leukocyte/technetium-99 m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med. 1990;31(5):549–56.

    PubMed  CAS  Google Scholar 

  62. Schauwecker DS, Park HM, Burt RW, Mock BH, Wellman HN. Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease. J Nucl Med. 1988;29(10):1651–5.

    PubMed  CAS  Google Scholar 

  63. Johnson JE, Kennedy EJ, Shereff MJ, Patel NC, Collier BD. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int. 1996;17(1):10–6.

    PubMed  CAS  Google Scholar 

  64. Blume PA, Dey HM, Daley LJ, Arrighi JA, Soufer R, Gorecki GA. Diagnosis of pedal osteomyelitis with Tc-99 m HMPAO labeled leukocytes. J Foot Ankle Surg. 1997;36(2):120–6. discussion 160.

    PubMed  CAS  Google Scholar 

  65. Croll SD, Nicholas GG, Osborne MA, Wasser TE, Jones S. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. J Vasc Surg. 1996;24(2):266–70.

    PubMed  CAS  Google Scholar 

  66. Hopfner S, Krolak C, Kessler S, et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 2004;25(12):890–5.

    PubMed  Google Scholar 

  67. Pinzur MS, Shields N, Trepman E, Dawson P, Evans A. Current practice patterns in the treatment of Charcot foot. Foot Ankle Int. 2000;21(11):916–20.

    PubMed  CAS  Google Scholar 

  68. Frykberg RG, Eneroth M. Principles of conservative management. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brook­landville, MD: Data Trace Publishing Company; 2010. p. 93–116.

    Google Scholar 

  69. Caputo GM, Ulbrecht J, Cavanagh PR, Juliano P. The Charcot foot in diabetes: six key points. Am Fam Physician. 1998;57(11):2705–10.

    PubMed  CAS  Google Scholar 

  70. Pinzur MS, Sage R, Stuck R, Kaminsky S, Zmuda A. A treatment algorithm for neuropathic (Charcot) midfoot deformity. Foot Ankle. 1993;14(4):189–97.

    PubMed  CAS  Google Scholar 

  71. Myerson MS, Henderson MR, Saxby T, Wilson-Short K. Management of midfoot diabetic neuroarthropathy. Foot Ankle. 1994;15(5):233–41.

    PubMed  CAS  Google Scholar 

  72. Pinzur M. Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int. 2004;25(8):545–9.

    PubMed  Google Scholar 

  73. Morgan JM, Biehl 3rd WC, Wagner Jr FW. Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop Relat Res. 1993;296:58–63.

    PubMed  Google Scholar 

  74. Armstrong DG, Short B, Nixon BP, Boulton AJM. Technique for fabrication of an “instant” total contact cast for treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc. 2002;92:405–8.

    PubMed  Google Scholar 

  75. Saltzman CL, Johnson KA, Goldstein RH, Donnelly RE. The patellar tendon-bearing brace as treatment for neurotrophic arthropathy: a dynamic force monitoring study. Foot Ankle. 1992;13:14–21.

    PubMed  CAS  Google Scholar 

  76. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994;11(1):28–31.

    PubMed  CAS  Google Scholar 

  77. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg. 2004;43(5):285–9.

    PubMed  Google Scholar 

  78. Pitocco D, Ruotolo V, Caputo S, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005;28(5):1214–5.

    PubMed  CAS  Google Scholar 

  79. Bem R, Jirkovska A, Fejfarova V, Skibova J, Jude EB. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care. 2006;29(6):1392–4.

    PubMed  CAS  Google Scholar 

  80. Bier RR, Estersohn HS. A new treatment for Charcot joint in the diabetic foot. J Am Podiatr Med Assoc. 1987;77(2):63–9.

    PubMed  CAS  Google Scholar 

  81. Hanft JR, Goggin JP, Landsman A, Surprenant M. The role of combined magnetic field bone growth stimulation as an adjunct in the treatment of neuroarthropathy/Charcot joint: an expanded pilot study. J Foot Ankle Surg. 1998;37(6):510–5. discussion 550–511.

    PubMed  CAS  Google Scholar 

  82. Grady JF, O’Connor KJ, Axe TM, Zager EJ, Dennis LM, Brenner LA. Use of electrostimulation in the treatment of diabetic neuroarthropathy. J Am Podiatr Med Assoc. 2000;90(6):287–94.

    PubMed  CAS  Google Scholar 

  83. Strauss E, Gonya G. Adjunct low intensity ultrasound in Charcot neuroarthropathy. Clin Orthop Relat Res. 1998;349:132–8.

    PubMed  Google Scholar 

  84. Hockenbury RT, Gruttadauria M, McKinney I. Use of implantable bone growth stimulation in Charcot ankle arthrodesis. Foot Ankle Int. 2007;28(9):971–6.

    PubMed  Google Scholar 

  85. Papa J, Myerson M, Girard P. Salvage with arthrodesis in intractable diabetic neuropathic arthropathy of the foot and ankle. J Bone Joint Surg Am. 1993;75A(7):1056–66.

    Google Scholar 

  86. Pinzur MS. Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity. Foot Ankle Int. 1999;20(9):564–7.

    PubMed  CAS  Google Scholar 

  87. Myerson MS, Alvarez RG, Lam PW. Tibiocalcaneal arthrodesis for the management of severe ankle and hindfoot deformities. Foot Ankle Int. 2000;21(8):643–50.

    PubMed  CAS  Google Scholar 

  88. Steindler A. The tabetic arthropathies. J Am Med Assoc. 1931;96:250.

    Google Scholar 

  89. Samilson RL, Sankaran B, Bersani FA, Smith AD. Orthopedic management of neuropathic joints. Arch Surg. 1959;78:119–21.

    Google Scholar 

  90. Johnson JT. Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment. J Bone Joint Surg Am. 1967;49(1):1–30.

    PubMed  CAS  Google Scholar 

  91. Heiple KG, Cammarn MR. Diabetic neuroarthropathy with spontaneous peritalar fracture-dislocation. A report of two cases. J Bone Joint Surg Am. 1966;48(6):1177–81.

    PubMed  CAS  Google Scholar 

  92. Baravarian B, Van Gils CC. Arthrodesis of the Charcot foot and ankle. Clin Podiatr Med Surg. 2004;21(2):271–89.

    PubMed  Google Scholar 

  93. Leventen EO. Charcot foot – a technique for treatment of chronic plantar ulcer by saucerization and primary closure. Foot Ankle. 1986;6(6):295–9.

    PubMed  CAS  Google Scholar 

  94. Catanzariti AR, Mendicino R, Haverstock B. Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg. 2000;39(5):291–300.

    PubMed  CAS  Google Scholar 

  95. Newman JH. Non-infective disease of the diabetic foot. J Bone Joint Surg Br. 1981;63B(4):593–6.

    PubMed  CAS  Google Scholar 

  96. Pinzur MS. Surgical management – history and general principles. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brook­landville, MD: Data Trace Publishing Company; 2010. p. 165–88.

    Google Scholar 

  97. Rosenblum BI, Giurini JM, Miller LB, Chrzan JS, Habershaw GM. Neuropathic ulcerations plantar to the lateral column in patients with Charcot foot deformity: a flexible approach to limb salvage. J Foot Ankle Surg. 1997;36(5):360–3.

    PubMed  CAS  Google Scholar 

  98. Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to nonoperative management of charcot arthropathy of the diabetic foot. J Bone Joint Surg Am. 2000;82-A(7):939–50.

    PubMed  CAS  Google Scholar 

  99. Wang JC, Le AW, Tsukuda RK. A new technique for Charcot’s foot reconstruction. J Am Podiatr Med Assoc. 2002;92(8):429–36.

    PubMed  Google Scholar 

  100. Jolly GP, Zgonis T, Polyzois V. External fixation in the management of Charcot neuroarthropathy. Clin Podiatr Med Surg. 2003;20(4):741–56.

    PubMed  Google Scholar 

  101. Farber DC, Juliano PJ, Cavanagh PR, Ulbrecht J, Caputo G. Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int. 2002;23(2):130–4.

    PubMed  Google Scholar 

  102. Thompson Jr RC, Clohisy DR. Deformity following fracture in diabetic neuropathic osteoarthropathy. Operative management of adults who have type-I diabetes. J Bone Joint Surg Am. 1993;75(12):1765–73.

    PubMed  Google Scholar 

  103. Marks RM, Parks BG, Schon LC. Midfoot fusion technique for neuroarthropathic feet: biomechanical analysis and rationale. Foot Ankle Int. 1998;19(8):507–10.

    PubMed  CAS  Google Scholar 

  104. Cooper PS. Application of external fixators for management of Charcot deformities of the foot and ankle. Semin Vasc Surg. 2003;16(1):67–78.

    PubMed  Google Scholar 

  105. Lamm BM, Paley D. Reduction of neuropathic foot deformity with gradual external fixation distraction and midfoot fusion. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 197–210.

    Google Scholar 

  106. Wukich DK, Zgonis T. Circular external fixation in Charcot neuroarthropathy. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 233–44.

    Google Scholar 

  107. Mendicino RW, Catanzariti AR, Saltrick KR, et al. Tibiotalocalcaneal arthrodesis with retrograde intramedullary nailing. J Foot Ankle Surg. 2004;43(2):82–6.

    PubMed  Google Scholar 

  108. Pinzur MS, Kelikian A. Charcot ankle fusion with a retrograde locked intramedullary nail. Foot Ankle Int. 1997;18(11):699–704.

    PubMed  CAS  Google Scholar 

  109. Moore TJ, Prince R, Pochatko D, Smith JW, Fleming S. Retrograde intramedullary nailing for ankle arthrodesis. Foot Ankle Int. 1995;16(7):433–6.

    PubMed  CAS  Google Scholar 

  110. Bevilacqua NJ, Rogers LC. Surgical management of charcot midfoot deformities. Clin Podiatr Med Surg. 2008;25(1):81–94.

    PubMed  Google Scholar 

  111. Bevilacqua NJ, Dankert JP, Rogers LC, Armstrong DG. A technique to protect external fixation devices. J Foot Ankle Surg. 2008;47(2):172–4.

    PubMed  Google Scholar 

  112. Rogers LC, Bevilacqua NJ, Frykberg RG, Armstrong DG. Predictors of postoperative complications of Ilizarov external ring fixators in the foot and ankle. J Foot Ankle Surg. 2007;46(5):372–5.

    PubMed  Google Scholar 

  113. Wukich DK, Belczyk RJ, Burns PR, Frykberg RG. Complications encountered with circular ring fixation in persons with diabetes mellitus. Foot Ankle Int. 2008;29(10):994–1000.

    PubMed  Google Scholar 

  114. Clohisy DR, Thompson RC. Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. J Bone Joint Surg Am. 1988;70A:1192–200.

    Google Scholar 

  115. Eckardt A, Schollner C, Decking J, et al. The impact of Syme amputation in surgical treatment of patients with diabetic foot syndrome and Charcot-neuro-osteoarthropathy. Arch Orthop Trauma Surg. 2004;124(3):145–50.

    PubMed  CAS  Google Scholar 

  116. Tan AL, Greenstein A, Jarrett SJ, McGonagle D. Acute neuropathic joint disease: a medical emergency? Diabetes Care. 2005;28(12):2962–4.

    PubMed  Google Scholar 

  117. Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med. 2005;22(12):1707–12.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert G. Frykberg DPM, MPH .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Frykberg, R.G., Rogers, L.C. (2012). Charcot Arthropathy in the Diabetic Foot. In: Veves, A., Giurini, J., LoGerfo, F. (eds) The Diabetic Foot. Contemporary Diabetes. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-791-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-791-0_20

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-790-3

  • Online ISBN: 978-1-61779-791-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics